Dose-dense Temozolomide: Is It Still Promising?

por NAGANE, Motoo
Publicado 2015

SS-1 Therapeutic challenges for glioblastoma: Temozolomide and its issues?

por Nagane, Motoo
Publicado 2020

IL-4 CHALLENGES FOR MANAGEMENT OF PRIMARY CNS LYMPHOMA

por Nagane, Motoo
Publicado 2022

Bevacizumab for Glioblastoma—A Promising Drug or Not?

por Nagane, Motoo, Nishikawa, Ryo
Publicado 2013

ML-12 MECHANISMS OF CELL DEATH INHIBITION THROUGH CHANGE IN SUBCELLULAR LOCALIZATION OF PIM-1 BY PIM1 GENE MUTATION RECURRENTLY FOUND IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

por Sasaki, Nobuyoshi, Ichimura, Koichi, Nagane, Motoo, Tomiyama, Arata
Publicado 2019

STMO-14 SURGICAL MANAGEMENT OF DEEP-SEATED GLIOMA AROUND THALAMUS

por Saito, Kuniaki, Kobayashi, Keiichi, Shimada, Daisuke, Iijima, Shohei, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

COT-19 TREATMENT EXPERIENCE OF AND TIPS FOR ADMINISTRATING NOVO TTF

por Shimada, Daisuke, Kobayashi, Keiichi, Saito, Kuniaki, Matsumoto, Yoshie, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

Nimotuzumab enhances temozolomide‐induced growth suppression of glioma cells expressing mutant EGFR in vivo

por Nitta, Yusuke, Shimizu, Saki, Shishido‐Hara, Yukiko, Suzuki, Kaori, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2016

COT-20 PERIOPERATIVE STATUS OF SERUM D-DIMER LEVEL AND VENOUS THROMBOSIS IN PATIENTS WITH MALIGNANT BRAIN TUMOR

por Shimada, Daisuke, Kobayashi, Keiichi, Saito, Kuniaki, Matsumoto, Yoshie, Iijima, Shohei, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

NQPC-07 IMMEDIATE POSTOPERATIVE REHABILITATION FOR PATIENTS WITH NEWLY-DIAGNOSED GLIOMA

por Ikeda, Mitsuyo, Yamada, Shin, Okajima, Yasutomo, Saito, Kuniaki, Kobayashi, Keiichi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

STMO-18 SUBPIAL RESECTION OF GLIOMA USING CUSA CLARITY

por Saito, Kuniaki, Kobayashi, Keiichi, Iijima, Shohei, Matsumoto, Yoshie, Shimada, Daisuke, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

PATH-05. A CASE OF PILOCYTIC ASTROCYTOMA HARBORING THE FGFR1 GENE MUTATION WITH A PREDOMINANT OLIGODENDROGLIOMA-LIKE COMPONENT

por Sasaki, Nobuyoshi, Chiba, Tomohiro, Saito, Kuniaki, Kobayashi, Keiichi, Shiokawa, Yoshiaki, Shibahara, Junji, Nagane, Motoo
Publicado 2020

Frontotemporal dermoid cyst with incomplete dermal sinus tract in an adult: A case report

por Hong, Sukwoo, Maruyama, Keisuke, Hatanaka, Ryo, Noguchi, Akio, Shimoyamada, Hiroaki, Nagane, Motoo, Shiokawa, Yoshiaki
Publicado 2020

COT-28 Questionnaire Survey Regarding Working Condition of the Members Belongs to the Japan Society for Neuro-Oncology (JSNO) by the Gender Equality and Diversity Committee of the...

por Fujiamaki, Takamitsu, Tamura, Kaoru, Abe, Tatsuya, Nakada, Mitsutoshi, Higuchi, Akiko, Watanabe, Yuko, Nagane, Motoo
Publicado 2021

COT-03 EVALUATING FUNCTIONING AND DISABILITY OF A PATIENT WITH BRAIN TUMOR BY WHODAS

por Ishita, Kohei, Ikeda, Mitsuyo, Yamada, Shin, Okajima, Yasutomo, Saito, Kuniaki, Kobayashi, Keiichi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

BT-09 CLINICAL AND MOLECULAR GENETIC FEATURE OF CEREBELLAR GLIOBLASTOMA

por Iijima, Shohei, Saito, Kuniaki, Shimizu, Saki, Kobayashi, Keiichi, Shimada, Daisuke, Matsumoto, Yoshie, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2019

STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery

por Saito, Kuniaki, Kobayashi, Keiichi, Shimada, Daisuke, Iijima, Shohei, Sasaki, Nobuyoshi, Sasaki, Yuta, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2020

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status

por Tabei, Yusuke, Kobayashi, Keiichi, Saito, Kuniaki, Shimizu, Saki, Suzuki, Kaori, Sasaki, Nobuyoshi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2020

STMO-9 Maximal safe glioma resection using high resolution exoscope

por Saito, Kuniaki, Sasaki, Nobuyoshi, Seiya, Yosuke, Onoda, Ryo, Kobayashi, Keiichi, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2021

NQPC-5 Does high-dose methotrexate-based chemotherapy for relapsed primary CNS lymphoma increase a risk of leukoencephalopathy with prior whole brain radiotherapy?

por Kobayashi, Keiichi, Sasaki, Nobuyoshi, Saito, Kuniaki, Yamagishi, Yuki, Hanayama, Naomi, Nakatomi, Hirofumi, Shiokawa, Yoshiaki, Nagane, Motoo
Publicado 2021